Tech Company Financing Transactions
MedGenome Funding Round
On 8/30/2022, MedGenome raised $50 million in funding from Novo Holdings and private investors.
Transaction Overview
Company Name
Announced On
8/30/2022
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Novo Holdings (Lead Investor) (Amit Kakar)
Proceeds Purpose
This latest round of funding will be used to broaden MedGenome's product offering and improve the reach of its key diagnostic services, including reproductive and oncology services, as well as the enhancement of MedGenome's bioinformatics and SaaS offerings.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
348 Hatch Dr.
Foster City, CA 94404
USA
Foster City, CA 94404
USA
Phone
Website
Email Address
Overview
MedGenome Inc. is a genomics-based diagnostics and research company delivering the best of health care by decoding genetic information contained in an individual's genome.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sam Santhosh
Chief Financial Officer
Surajit Chakrabartty
Chief Operating Officer
V L Ramprasad
Chief Scientific Officer
Andrew Peterson
Co-Founder
Mahesh Pratapneni
Vice President
Eric Stawiski
VP - Bus. Development
Sanjay Sharma
VP - Bus. Development
Shankar Sikri
VP - Marketing
Hiranjith G H
VP - R & D
Amitabha Chaudhuri
Browse more venture capital transactions:
Prev: 8/30/2022: Mavenoid venture capital transaction
Next: 8/30/2022: Mermade Seafoods venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs